In an article from Malaysia local newspaper, 13.3 percent of the population is facing obesity while 38.5 percent are considered overweight. Bad dietary habit is the root cause of this problem. If one is looking closer to a very typical meals options for individual, it is not difficult to understand why.
We are pleased to announce that Monteloeder has been nominated as Finalist in the “Editor’s Award for Innovation” for the Nutraingredients Awards in Vitafoods Europe, held in Geneva on May 15-17. Over 20,000 attendees are expected to visit the meeting, making it one of the largest in Europe.
Besides exhibiting, we will provide a presentation for the award entitled: “Digital Nutraceutics, the Paradigm Shift: Metabolaid; a Case Study.” Here, we will explain Monteloeder’s digitalization approach in the nutraceutical sector. Monteloeder is quickly becoming a reference in digital health, with products that are currently available combining supplementation and digitization, such as Nutroxsun and more recently Metabolaid. Specifically, Metabolaid will be presented in the meeting, which is an ingredient that has been clinically proven to help consumers lose weight by helping them control their appetite.
The winners of the awards will be announced on May 16th, during the Awards Dinner.
We thank Vitafoods Europe for our candidacy to the Award. Hope to see you there!
The last day January 22nd, an agreement was signed for the clinical trial of the MetabolAid H2020 project, an SME instrument between Monteloeder and the Universidad Católica de Murcia (UCAM).
Yesterday, Monteloeder presented at a press conference at the University Miguel Hernandez in Elche, the distinction granted by the European Commission (project EU_H2020) for the launching and marketing MetabolAid, an ingredient that provides the solution for Metabolic Syndrome.
Monteloeder would like to thank Mr. Marco Cecchetto (Project Adviser European Commission); Magnífico Mr. D. Jesús Tadeo Pastor (Rector of the UMH); Mr. Manuel Jordá (Vice-rector for Investigation and Innovation of the UMH); and Sr. Vicente Micol (Vice-rector for International Relations of the UMH) for assisting to the press conference.
In addition, the owner of a business Monteloeder, Sr. Ignacio Cartagena and Arturo Lizón Ph.D. (CEO of Monteloeder), as representatives of the company.
Moreover, we would like to thank the media support because we had a massive participation of the mass media, which picked the story up:
-Diario Información: Un freno natural contra la obesidad
OVERVIEW OF THE PRESS CONFERENCE
We are pleased to announce that Monteloeder has been nominated as Finalist in the “Future of Nutrition Award” of the Food Ingredients Europe Meeting. Food Ingredients (FI) is one of the most important food & beverage innovation meetings in the world, with over 1800 exhibitors and an estimated 26,000 attendees. Some of the most renown companies of the sector that will assist include Danone, Heinz, Kraft Foods, and Pepsico, among others.
Our New Product Development Manager, Dr. Jonathan Jones, will be representing Monteloeder for the Award, with a presentation entitled “Digitization of functional foods/ beverages with an impact on consumer’s health and wellbeing.” Dr. Jones will explain to the judges Monteloeder´s digitization approach in the nutraceutical sector, and its implications in food and beverages. Monteloeder is quickly becoming a reference in digital health, with products that are currently available combining supplementation and digitization, such as Nutroxsun and more recently Metabolaid. It is the latter product of which Dr. Jones will present and explain to the judges of the Award, which is an ingredient that has been clinically proven to help consumers lose weight by helping them control their appetite.
The winners of the awards will be announced on November 28th, during the Awards Ceremony at 18:00. If any assistant or visitor wishes to contact him for a meeting, please send him an email at email@example.com. He will be more than happy to give you more information!
We thank FI Europe for our candidacy to the Award, and wish all the best for Dr. Jones.
Metabolic syndrome is a growing epidemic, which if not treated can give rise to more serious health-related complications such as cardiovascular disease, diabetes, and cancer. It is considered that an individual has metabolic syndrome when he/she presents at least 3 of the following risk factors:
Anyone who has tried a given diet knows that in the end, those lost pounds always come back, and many times with new friends. Why is it so difficult to lose weight, and yet so easy to gain it back? Well, don’t worry, it´s not (always) your fault.